ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $62,000 | +100.0% | 30,133 | +147.4% | 0.01% | +66.7% |
| Q4 2020 | $31,000 | +24.0% | 12,182 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | -84.6% | 11,194 | -76.7% | 0.00% | -66.7% |
| Q2 2019 | $162,000 | +194.5% | 48,036 | +262.9% | 0.01% | +200.0% |
| Q3 2018 | $55,000 | -3.5% | 13,237 | +28.3% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | -73.1% | 10,321 | -49.1% | 0.00% | -70.0% |
| Q3 2017 | $212,000 | – | 20,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |